Hydrogen as a complementary therapy against ischemic stroke: A review of the evidence.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 07 09 2018
revised: 29 10 2018
accepted: 02 11 2018
pubmed: 12 12 2018
medline: 23 7 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Ischemic stroke is one of the most common sources of mortality in the world. Researchers have been trying to find a complementary therapy to treat ischemic stroke in order to improve its prognosis and expand the therapeutic window for reperfusion treatment. For this reason, many experimental and clinical trials studying the effects of hydrogen against ischemic stroke have been published. Hydrogen gas has been found to eliminate hydroxyl free radical and peroxynitrite anions as well as producing therapeutic effect in patients with ischemic stroke. Many studies have been published illustrating its anti-oxidative, anti-inflammatory and anti-apoptotic effects. The purpose of this article is to review the literature concerning treatment of cerebral I/R injury or ischemic stroke with hydrogen therapy. Specifically, we will examine the appropriate laboratory methods, mechanisms of hydrogen therapy, and outcomes of relevant clinical trials. We conclude this review with a discussion on future investigations of hydrogen therapy to treat ischemic stroke.

Identifiants

pubmed: 30529801
pii: S0022-510X(18)30457-X
doi: 10.1016/j.jns.2018.11.004
pii:
doi:

Substances chimiques

Antioxidants 0
Hydrogen 7YNJ3PO35Z

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-246

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

He Li (H)

Department of Neurosurgery, Changhai Hospital, Shanghai 200433, People's Republic of China; Postgraduate School, Navy Medical University, Shanghai 200433, People's Republic of China.

Yin Luo (Y)

Department of Neurosurgery, Changhai Hospital, Shanghai 200433, People's Republic of China.

Pengfei Yang (P)

Department of Neurosurgery, Changhai Hospital, Shanghai 200433, People's Republic of China.

Jianmin Liu (J)

Department of Neurosurgery, Changhai Hospital, Shanghai 200433, People's Republic of China. Electronic address: chstroke@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH